Exercise suppresses tumor growth independent of high fat food intake and associated immune dysfunction.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
31 03 2022
31 03 2022
Historique:
received:
10
02
2019
accepted:
11
03
2022
entrez:
1
4
2022
pubmed:
2
4
2022
medline:
5
4
2022
Statut:
epublish
Résumé
Epidemiological data suggest that exercise training protects from cancer independent of BMI. Here, we aimed to elucidate mechanisms involved in voluntary wheel running-dependent control of tumor growth across chow and high-fat diets. Access to running wheels decreased tumor growth in B16F10 tumor-bearing on chow (- 50%) or high-fat diets (- 75%, p < 0.001), however, tumor growth was augmented in high-fat fed mice (+ 53%, p < 0.001). Tumor growth correlated with serum glucose (p < 0.01), leptin (p < 0.01), and ghrelin levels (p < 0.01), but not with serum insulin levels. Voluntary wheel running increased immune recognition of tumors as determined by microarray analysis and gene expression analysis of markers of macrophages, NK and T cells, but the induction of markers of macrophages and NK cells was attenuated with high-fat feeding. Moreover, we found that the regulator of innate immunity, ZBP1, was induced by wheel running, attenuated by high-fat feeding and associated with innate immune recognition in the B16F10 tumors. We observed no effects of ZBP1 on cell cycle arrest, or exercise-regulated necrosis in the tumors of running mice. Taken together, our data support epidemiological findings showing that exercise suppresses tumor growth independent of BMI, however, our data suggest that high-fat feeding attenuates exercise-mediated immune recognition of tumors.
Identifiants
pubmed: 35361802
doi: 10.1038/s41598-022-08850-5
pii: 10.1038/s41598-022-08850-5
pmc: PMC8971502
doi:
Substances chimiques
RNA-Binding Proteins
0
Zbp1 protein, mouse
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
5476Informations de copyright
© 2022. The Author(s).
Références
Nutr Metab (Lond). 2019 Sep 12;16:63
pubmed: 31528182
Nat Immunol. 2018 Dec;19(12):1330-1340
pubmed: 30420624
PLoS One. 2020 Mar 18;15(3):e0229290
pubmed: 32187204
J Clin Oncol. 2006 Aug 1;24(22):3527-34
pubmed: 16822844
Breast Cancer Res Treat. 2016 Oct;159(3):469-79
pubmed: 27601139
Nat Rev Endocrinol. 2014 Aug;10(8):455-465
pubmed: 24935119
Exp Biol Med (Maywood). 2007 Nov;232(10):1289-99
pubmed: 17959841
Cell Metab. 2020 Jan 7;31(1):148-161.e5
pubmed: 31761565
Cell Metab. 2016 Mar 8;23(3):554-62
pubmed: 26895752
Trends Immunol. 2015 Feb;36(2):92-101
pubmed: 25616716
Int J Mol Sci. 2020 May 27;21(11):
pubmed: 32471301
J Clin Oncol. 2018 Mar 20;36(9):875-883
pubmed: 29356607
Nat Rev Endocrinol. 2014 Dec;10(12):737-48
pubmed: 25311396
Am J Physiol Endocrinol Metab. 2012 Jan 1;302(1):E108-16
pubmed: 21952038
Cell. 2020 Dec 23;183(7):1848-1866.e26
pubmed: 33301708
Nat Rev Gastroenterol Hepatol. 2011 Apr;8(4):224-38
pubmed: 21386810
Nat Rev Cancer. 2008 Mar;8(3):205-11
pubmed: 18235448
Cell Metab. 2018 Jan 9;27(1):10-21
pubmed: 29056514
Acta Oncol. 2020 Dec;59(12):1447-1454
pubmed: 32935602
Trends Mol Med. 2016 Feb;22(2):88-98
pubmed: 26776093
Nat Rev Cancer. 2015 Aug;15(8):484-98
pubmed: 26205341
Cell. 2013 Nov 21;155(5):1088-103
pubmed: 24267891
Nature. 2007 Jul 26;448(7152):501-5
pubmed: 17618271
J Physiol. 2009 Dec 1;587(Pt 23):5559-68
pubmed: 19752112
Obesity (Silver Spring). 2015 Nov;23(11):2233-41
pubmed: 26390898
BMC Obes. 2015 Jan 24;2:1
pubmed: 26217516
Cancer Prev Res (Phila). 2009 Jul;2(7):641-9
pubmed: 19549797
Dev Cell. 2021 Feb 22;56(4):461-477.e7
pubmed: 33621493
J Natl Cancer Inst. 2012 Jun 6;104(11):815-40
pubmed: 22570317
JAMA. 2005 May 25;293(20):2479-86
pubmed: 15914748
J Clin Oncol. 2011 Feb 20;29(6):726-32
pubmed: 21205749
Cancer Res. 2017 Sep 15;77(18):4894-4904
pubmed: 28887324
JAMA Intern Med. 2016 Jun 1;176(6):816-25
pubmed: 27183032
Trends Cancer. 2017 Jun;3(6):423-441
pubmed: 28718417
Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):146-153
pubmed: 29141853
iScience. 2020 Apr 24;23(4):100978
pubmed: 32240949
Cell. 2018 Sep 20;175(1):159-170.e16
pubmed: 30241606
Endocr Relat Cancer. 2018 Jan;25(1):11-19
pubmed: 29018055
Nat Cell Biol. 2016 Dec;18(12):1357-1366
pubmed: 27820601